Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma : Final Results of a Randomized Phase III Study - Kwak, Larry W. (Comprehensive Cancer Center, Duarte) ; Sancho, Juan Manuel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Cho, Seok Goo (The Catholic University of Korea, Seoul, South Korea) ; Nakazawa, Hideyuki (Shinshu University School of Medicine, Nagano, Japan) ; Suzumiya, Junji (Shimane University Hospital, Innovative Cancer Center/Oncology-Hematology, Izumo, Japan) ; Tumyan, Gayane (Division of Hematology and Bone Marrow Transplantation, Blokhin Russian Cancer) ; Kim, Jin Seok (Yonsei University College of Medicine, Severance Hospital, Seoul, South Korea) ; Menne, Tobias (Newcastle University, UK) ; Mariz, José (Instituto Português de Oncología do Porto) ; Ilyin, Nikolai (Ministry of Health of the Russian Federation) ; Jurczak, Wojciech (Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland) ; Lopez Martinez, Aurelio (Hospital Arnau de Vilanova (València)) ; Samoilova, Olga (Nizhniy Novgorod Region Clinical Hospital, Nizhniy Novgorod, Russia) ; Zhavrid, Edvard (N. N. Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology, Belarus) ; Yañez Ruiz, Eduardo (Universidad de la Frontera, Temuco, Chile) ; Trneny, Marek (Charles University, Czech Republic) ; Popplewell, Leslie (Toni Stephenson Lymphoma Cancer Center and Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA) ; Ogura, Michinori (Kasugai Municipal Hospital, Aichi 486-8510, Japan.) ; Kim, Wong Seog (Sungkyunkwan University School of Medicine, Seoul, South Korea) ; Lee, Sang Joon (Celltrion. Inc, South Korea) ; Kim, Sung Hyun (Celltrion. Inc, South Korea) ; Ahn, Keum Young (Celltrion. Inc, South Korea) ; Buske, Christian (University Hospital of Ulm, Germany)
 
Comentaris (0) | Ressenyes (0)
Enceteu un debat sobre qualsevol aspecte d'aquest document.

 Subscriure's to this discussion. You will then receive all new comments by email.

Afegeix un comentari


Un cop identificats, els usuaris autoritzats també hi poden adjuntar fitxers.
Vigileu: encara no heu definit el vostre àlies.
N/D s'usarà temporalment com a autor d'aquest comentari.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>